Common mouse models of tauopathy reflect early but not late human disease.

Authors:
Wenger K; Viode A; Schlaffner CN; van Zalm P; Cheng L and 11 more

Journal:
Mol Neurodegener

Publication Year: 2023

DOI:
10.1186/s13024-023-00601-y

PMCID:
PMC9893608

PMID:
36732784

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mol Neurodegener

Abbreviation: Mol Neurodegener

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including towar…
Sepulveda J; Kim JY; Binder J and 2 more (2024) - Transparency Score: 3/6
Cognitive, functional, and neuropsychiatric correlates of regional tau pathology in autopsy-confirm…
Alosco ML; White M; Bell C and 21 more (2024) - Transparency Score: 3/6
Collagen in the central nervous system: contributions to neurodegeneration and promise as a therape…
Wareham LK; Baratta RO; Del Buono BJ and 2 more (2024) - Transparency Score: 2/6
CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegene…
Mravinacová S; Alanko V; Bergström S and 8 more (2024) - Transparency Score: 3/6
Fluid biomarkers for amyotrophic lateral sclerosis: a review.
Irwin KE; Sheth U; Wong PC and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"availability of data and materials the datasets generated during the current study are available via proteomexchange with the dataset identifier pxd033965."

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll procedures and experiments were approved by the AbbVie Institutional Animal Care and Use Committee (IACUC). Consent for publicationAll authors have approved of the consents of this manuscript and provided consent for publication. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by grants from the National Institutes of Health R01 AG071858 and P30AG 062421."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025